Crossref
What are the benefits and harms of prophylactic macrolide antibiotics for preventing bronchopulmonary dysplasia (BPD) in very preterm, ventilated neonates?
Cochrane Clinical Answers · 19.05.2026
DOI: 10.1002/cca.4778 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cochrane Clinical Answers, online erschienen am 19.05.2026. Verfasst von Nai Ming Lai. Die Arbeit nennt 21 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Lai, N. M. (2026). What are the benefits and harms of prophylactic macrolide antibiotics for preventing bronchopulmonary dysplasia (BPD) in very preterm, ventilated neonates?. Cochrane Clinical Answers. https://doi.org/10.1002/cca.4778
Vancouver
Lai NM. What are the benefits and harms of prophylactic macrolide antibiotics for preventing bronchopulmonary dysplasia (BPD) in very preterm, ventilated neonates?. Cochrane Clinical Answers. 2026. doi:10.1002/cca.4778
BibTeX
@article{Lai2026,
author = {Lai, Nai Ming},
title = {What are the benefits and harms of prophylactic macrolide antibiotics for preventing bronchopulmonary dysplasia (BPD) in very preterm, ventilated neonates?},
journal = {Cochrane Clinical Answers},
year = {2026},
doi = {10.1002/cca.4778}
}
EUVIMED